New Respiratory Virus Spreading in California: What to Know

A respiratory virus for which there is currently no vaccine or specific treatment is circulating in parts of California, prompting increased monitoring by public health officials. While not yet cause for widespread alarm, the rise in human metapneumovirus (HMPV) cases—detected primarily through wastewater surveillance—is a reminder of the ongoing challenges posed by respiratory illnesses, particularly as we move further from the peak of COVID-19 concerns.

Wastewater Signals and Geographic Distribution

The presence of HMPV has been identified in wastewater samples across a significant portion of California. Data from Stanford University’s WastewaterSCAN project indicates high concentrations of the virus in the Inland Empire and Northern California, specifically in Sacramento, San Francisco, Santa Rosa, Davis, Napa, Marin, Vallejo, and Novato. Southern California is too showing detections, though at varying levels. Concentrations are low in the Los Angeles metro area, medium in cities like Long Beach and Torrance, and high in San Bernardino County, including areas like Chino and Ontario.

Wastewater surveillance has become an increasingly important tool for tracking infectious diseases. By analyzing samples from sewage treatment plants, public health agencies can gain insights into the prevalence of viruses within a community, even before individuals begin seeking medical care. This method offers a relatively inexpensive and non-invasive way to monitor disease trends at a local and regional level.

Understanding Human Metapneumovirus (HMPV)

HMPV is a common respiratory virus that typically circulates during the winter and spring months. According to the Centers for Disease Control and Prevention (CDC), it can cause illness ranging from mild cold-like symptoms to more severe respiratory infections, such as pneumonia and bronchiolitis. The CDC provides detailed information on HMPV, including symptoms, transmission, and prevention. The virus spreads through close contact with infected individuals, contact with contaminated surfaces, and through respiratory droplets produced when an infected person coughs or sneezes.

Symptoms of HMPV are similar to those of other respiratory viruses, including fever, cough, sore throat, runny nose, and difficulty breathing. While most people recover within a week or two, HMPV can be more serious for infants, young children, older adults, and people with weakened immune systems. There is currently no specific antiviral treatment or vaccine available for HMPV.

Why is HMPV circulating now?

Dr. Monica Gandhi, an infectious disease expert at the University of California, San Francisco, suggests that the current rise in HMPV is linked to a decrease in COVID-19 rates. “This season, unlike the past four winters, we did not have high rates of COVID-19, allowing other viruses to flourish,” she explained, as reported by Yahoo News. The absence of widespread COVID-19 immunity and preventative measures may have created an environment where other respiratory viruses, like HMPV, could spread more easily. Colder temperatures and increased indoor gatherings during the fall and winter months contribute to the transmission of respiratory pathogens.

The Role of Respiratory Virus Surveillance

The California Department of Public Health (CDPH) maintains a Respiratory Virus Dashboard that provides weekly updates on the activity and severity of flu, RSV, and COVID-19. This dashboard, along with wastewater surveillance data, allows public health officials to track trends, identify outbreaks, and inform public health recommendations. It’s important to note that the dashboard currently focuses on flu, RSV, and COVID-19, and specific HMPV data may not be as readily available through this source.

The ongoing surveillance efforts are crucial for understanding the evolving landscape of respiratory viruses and for preparing for future outbreaks. By monitoring viral activity, public health agencies can identify emerging threats, assess the effectiveness of interventions, and provide timely guidance to the public.

What This Means for Individuals

While the rise in HMPV is being closely monitored, public health officials emphasize that there is no need for widespread panic. The virus typically causes mild illness in most people, and there are steps individuals can take to protect themselves and others. These include practicing good hygiene, such as frequent handwashing, covering coughs and sneezes, and staying home when sick. Ventilation, particularly in indoor spaces, is also important to reduce the spread of respiratory viruses.

It’s important to remember that HMPV is just one of many respiratory viruses that circulate each year. Other common viruses, such as influenza and respiratory syncytial virus (RSV), can also cause significant illness, particularly in vulnerable populations. Staying up-to-date on vaccinations, including the annual flu vaccine and the RSV vaccine for eligible individuals, is an important step in protecting yourself and your community.

What comes next: Ongoing monitoring and data analysis

Public health agencies will continue to monitor HMPV activity through wastewater surveillance and clinical reporting. The data collected will be used to refine our understanding of the virus, identify risk factors, and inform public health recommendations. Further research is needed to develop effective treatments and vaccines for HMPV, but for now, the focus remains on prevention and early detection. Individuals experiencing respiratory symptoms should consult with a qualified healthcare professional for diagnosis and appropriate care.